Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Buck

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA Network Open|February 1, 2023
Frequency and Characteristics of Trials Using Medical Writer Support in High-Impact Oncology JournalsEva Buck, Alyson Haslam, Jordan Tuia, et al.
Neurochemistry International|August 23, 2017
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's diseaseNoemi Pasquarelli, Christoph Porazik, Hanna Bayer, et al.
Neurobiology of Disease|August 14, 2021
HAP40 protein levels are huntingtin-dependent and decrease in Huntington diseaseBin Huang, Manuel Seefelder, Eva Buck, et al.
Frontiers in Molecular Neuroscience|June 13, 2017
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse ModelsEva Buck, Hanna Bayer, Katrin S Lindenberg, et al.
Neuropharmacology|April 5, 2017
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALSNoemi Pasquarelli, Michael Engelskirchen, Johannes Hanselmann, et al.
Plos One|April 14, 2017
High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory functionEva Buck, Martina Zügel, Uwe Schumann, et al.
Neurobiology of Disease|September 26, 2022
Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's diseaseWolfgang P Ruf, Annette Palmer, Lena Dörfer, et al.
Human Genomics|July 28, 2023
Mitochondrial genome study in blood of maternally inherited ALS casesSarah J Brockmann, Eva Buck, Tiziana Casoli, et al.
Acta Neuropathologica|May 18, 2022
Increased NF-L levels in the TDP-43<sup>G298S</sup> ALS mouse model resemble NF-L levels in ALS patientsEva Buck, Patrick Oeckl, Veselin Grozdanov, et al.
Neurobiology of Disease|November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissuesHanna Bayer, Kerstin Lang, Eva Buck, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA Network Open|February 1, 2023
Frequency and Characteristics of Trials Using Medical Writer Support in High-Impact Oncology JournalsEva Buck, Alyson Haslam, Jordan Tuia, et al.
Neurochemistry International|August 23, 2017
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's diseaseNoemi Pasquarelli, Christoph Porazik, Hanna Bayer, et al.
Neurobiology of Disease|August 14, 2021
HAP40 protein levels are huntingtin-dependent and decrease in Huntington diseaseBin Huang, Manuel Seefelder, Eva Buck, et al.
Frontiers in Molecular Neuroscience|June 13, 2017
Comparison of Sirtuin 3 Levels in ALS and Huntington's Disease-Differential Effects in Human Tissue Samples vs. Transgenic Mouse ModelsEva Buck, Hanna Bayer, Katrin S Lindenberg, et al.
Neuropharmacology|April 5, 2017
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALSNoemi Pasquarelli, Michael Engelskirchen, Johannes Hanselmann, et al.
Plos One|April 14, 2017
High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington's disease expansion mutation carriers shows normal mitochondrial respiratory functionEva Buck, Martina Zügel, Uwe Schumann, et al.
Neurobiology of Disease|September 26, 2022
Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's diseaseWolfgang P Ruf, Annette Palmer, Lena Dörfer, et al.
Human Genomics|July 28, 2023
Mitochondrial genome study in blood of maternally inherited ALS casesSarah J Brockmann, Eva Buck, Tiziana Casoli, et al.
Acta Neuropathologica|May 18, 2022
Increased NF-L levels in the TDP-43<sup>G298S</sup> ALS mouse model resemble NF-L levels in ALS patientsEva Buck, Patrick Oeckl, Veselin Grozdanov, et al.
Neurobiology of Disease|November 8, 2016
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissuesHanna Bayer, Kerstin Lang, Eva Buck, et al.
Pageof 2